Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Medexus Secures Strong Q1 2026 with Successful Launch of New Drug GRAFAPEX
Date 18 August 2025

Medexus Secures Strong Q1 2026 with Successful Launch of New Drug GRAFAPEX

Medexus Wins this Quarter's Race with the Successful Debut of its New Drug Announcement Medexus Pharmaceuticals smartly achieved a modest revenue winner position in this quarter for its energize...

Concentra Biosciences Resumes Aggressive Biotech Deals After a Quiet 2024
Date 18 August 2025

Concentra Biosciences Resumes Aggressive Biotech Deals After a Quiet 2024

Concentra, After a Steady 2024, is Back for Dealmaking with Many Biotech Firms Concentra Biosciences Comeback One of the busiest buyers of biotech has been suspicious. Concentra Biosciences, the...

Ocugen Secures $20 Million in Registered Direct Offering with Janus Henderson
Date 18 August 2025

Ocugen Secures $20 Million in Registered Direct Offering with Janus Henderson

Ocugen Closed the Registered Direct Offering at $20 Million Announcement Ocugen Inc., a leading biotechnology company in gene therapies for blindness diseases, closed its previously introduced r...

Modular Medical Showcases Pivot Pump and Gamified Training at ADCES 2025
Date 14 August 2025

Modular Medical Showcases Pivot Pump and Gamified Training at ADCES 2025

Modular Medical’s Participation at the ADCES  Announcement Modular Medical Inc., a leading insulin delivery technology company with its first-ever FDA-approved patch pump introduced m...

Ocugen Signs $20 Million Securities Purchase Deal with Janus Henderson Investors
Date 14 August 2025

Ocugen Signs $20 Million Securities Purchase Deal with Janus Henderson Investors

Ocugen’s and Janus Securities' Purchase Agreement Announcement Ocugen Inc., a global biotechnology company in gene therapies for blindness diseases, signed a securities purchase agreement...

Five New Oral Obesity Drug Candidates Could Challenge Lilly's Orforglipron
Date 14 August 2025

Five New Oral Obesity Drug Candidates Could Challenge Lilly's Orforglipron

Five Oral Obesity Candidates, a Competition to Lilly’s Orforglipron Lilly’s Orforglipron’ The Phase 3 data for Eli Lilly’s early oral GLP-1 therapy, orforglipron, were re...

Orchestra Biomed Expands Patient Eligibility for FDA-Approved BACKBEAT Study
Date 14 August 2025

Orchestra Biomed Expands Patient Eligibility for FDA-Approved BACKBEAT Study

Orchestra’s Rollout of the FDA-approved Protocol Update Announcement Orchestra Biomed Holdings, Inc., a leading biomedical company elevating excellent technologies to patients via risk-rew...

Fibrothelium Partners with Vivolta to Manufacture SimplySilk® Membrane for Bone Regeneration
Date 13 August 2025

Fibrothelium Partners with Vivolta to Manufacture SimplySilk® Membrane for Bone Regeneration

Fibrothelium and Vivolta Entered into a Manufacturing Contract Announcement Vivolta, a medical mechanism solution provider, entered a long-term contract with Fibrothelium, a pioneer in silk prot...

Cognition Therapeutics Reports Strong Q2 2025 Results and Advances Alzheimer's and DLB Drug Development
Date 13 August 2025

Cognition Therapeutics Reports Strong Q2 2025 Results and Advances Alzheimer's and DLB Drug Development

Cognition’s Progressive Clinical Programs and Financial Results for the Second Quarter of 2025 Announcement Cognition Therapeutics Inc., a leading clinical-stage company producing advanced...

Trinity Biotech Launches FDA-Approved Preeclampsia Testing Service for Maternal Health
Date 13 August 2025

Trinity Biotech Launches FDA-Approved Preeclampsia Testing Service for Maternal Health

Trinity Officially Launched its FDA-approved Preeclampsia Testing Service Announcement Trinity Biotech plc, a leading commercial-stage biotechnology company targeting diabetes management solutio...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.